Latest Period
Q1 2026
Security Snapshot
Whitehawk Therapeutics, Inc. - Common Stock (WHWK) Institutional Ownership
CUSIP: 00032Q104
13F Institutional Holders and Ownership History from Q3 2021 to Q2 2026
Institutions Reporting
60
Shares (Excl. Options)
34,244,810
Price
$3.45
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- WHWK on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 34,244,810
- Total 13F value
- $118,155,300
- Portfolio coverage rank
- 0%
- Share change
- +1,306,634
- Value change
- +$4,672,362
- Number of holders
- 60
- Shares outstanding
- 53,819,722
- SEC-reported price per share
- $3.96
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- WHWK - Whitehawk Therapeutics, Inc. - Common Stock is tracked under CUSIP 00032Q104.
- 60 institutions reported positions in Q1 2026.
- 12 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 60 to 8 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $118,155,300 to $305,893.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 60 institutions filings for Q1 2026.
Security key
00032Q104
Latest holder period
Q1 2026
13F holders
60
13D/G owners
12
CIK / CUSIP context first
Open Q1 2026 holders
WHWK full holder history
Whitehawk Therapeutics, Inc. SEC filings
Whitehawk Therapeutics, Inc. company facts
Whitehawk Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00032Q104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
12
Security
WHWK
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 20% | 0% | $64,207,289 | +$22,385,776 | 18,292,675 | +54% | Behzad Aghazadeh | 12 May 2026 |
| ACUTA CAPITAL PARTNERS, LLC | 9% | +15% | $17,001,650 | +$10,257,898 | 4,843,775 | +152% | ANUPAM DALAL | 14 May 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10% | $7,280,365 | 4,727,510 | SUVRETTA CAPITAL MANAGEMENT, LLC | 04 Mar 2025 | |||
| ORBIMED ADVISORS LLC | 8.9% | $6,415,640 | 4,166,000 | OrbiMed Advisors LLC | 31 Mar 2025 | |||
| ABG Management Ltd. | 6.3% | $4,488,492 | 2,914,605 | Fan Yu | 04 Mar 2025 | |||
| Coastlands Capital LP | 6% | $5,074,587 | 2,819,215 | Coastlands Capital LP | 19 Aug 2025 | |||
| BML Investment Partners, L.P. | 5% | -49% | $3,749,900 | -$331,178 | 2,435,000 | 0% | Leonard Braden Michael | 05 Mar 2025 |
| QVT Financial LP | 9.4% | $3,563,101 | 2,313,702 | QVT Financial LP | 31 Dec 2024 | |||
| Desai Neil | 4.9% | -48% | $3,500,329 | +$14,438 | 2,272,941 | +0.41% | Neil Desai | 04 Mar 2025 |
| EcoR1 Capital, LLC | 1.4% | $531,690 | 345,253 | EcoR1 Capital, LLC | 31 Dec 2024 | |||
| Point72 Asset Management, L.P. | 0% | -100% | $7,834 | -$2,256,445 | 5,087 | -100% | Point72 Asset Management, L.P. | 31 Mar 2025 |
| Satter Muneer A | 0% | $1,015 | 659 | Satter Muneer A | 31 Dec 2024 |
As of 31 Mar 2026, 60 institutional investors reported holding 34,244,810 shares of Whitehawk Therapeutics, Inc. - Common Stock (WHWK). This represents 64% of the company’s total 53,819,722 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
62%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| QVT Financial LP | 8.6% | 4,615,709 | 0% | 1.3% | $15,924,196 |
| ORBIMED ADVISORS LLC | 7.7% | 4,166,000 | 0% | 0.33% | $14,372,700 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.9% | 3,700,000 | 0% | 0.35% | $12,765,000 |
| ACUTA CAPITAL PARTNERS, LLC | 6.3% | 3,410,402 | 0% | 8.4% | $11,765,887 |
| Avoro Capital Advisors LLC | 5.3% | 2,849,402 | 0% | 0.1% | $9,830,437 |
| KVP Capital Advisors, LP | 4% | 2,165,997 | 0% | 5.6% | $7,472,690 |
| Siren, L.L.C. | 3.9% | 2,082,000 | 0% | 0.2% | $7,182,900 |
| Yu Fan | 3.8% | 2,070,000 | 0% | 7.4% | $7,141,500 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.4% | 1,315,770 | 0% | 0% | $4,539,407 |
| ACORN CAPITAL ADVISORS, LLC | 2.1% | 1,139,363 | 0% | 1.1% | $3,930,802 |
| STEMPOINT CAPITAL LP | 1.7% | 939,369 | -36% | 0.62% | $3,240,823 |
| Ally Bridge Group (NY) LLC | 1.5% | 817,939 | 0% | 2.8% | $2,821,890 |
| Balyasny Asset Management L.P. | 1% | 550,441 | 0% | $1,899,021 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.85% | 457,540 | +7.5% | 0% | $1,579,172 |
| RENAISSANCE TECHNOLOGIES LLC | 0.8% | 428,622 | -2.7% | 0% | $1,478,746 |
| BlackRock, Inc. | 0.65% | 351,385 | +18% | 0% | $1,212,278 |
| MILLENNIUM MANAGEMENT LLC | 0.58% | 309,674 | 0% | $1,068,375 | |
| Eversept Partners, LP | 0.57% | 306,800 | +18% | 0.07% | $1,058,460 |
| Woodline Partners LP | 0.52% | 281,497 | 0% | $971,165 | |
| TWO SIGMA INVESTMENTS, LP | 0.51% | 273,482 | -12% | 0% | $943,513 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.4% | 215,284 | 0% | 0.01% | $742,730 |
| VANGUARD FIDUCIARY TRUST CO | 0.4% | 214,827 | 0% | 0% | $741,153 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.38% | 203,465 | +85% | 0% | $701,954 |
| STATE STREET CORP | 0.3% | 160,382 | +10% | 0% | $553,318 |
| JANE STREET GROUP, LLC | 0.28% | 151,110 | +116% | 0% | $521,330 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 66,804 | $305,893 | +$190,367 | $4.58 | 8 |
| 2026 Q1 | 34,244,810 | $118,155,300 | +$4,672,362 | $3.45 | 60 |
| 2025 Q4 | 32,977,477 | $79,245,821 | +$5,008,841 | $2.42 | 47 |
| 2025 Q3 | 28,831,370 | $54,340,996 | -$1,110,993 | $1.90 | 39 |
| 2025 Q2 | 29,433,136 | $54,608,497 | -$4,256,988 | $1.87 | 38 |
| 2025 Q1 | 31,810,129 | $56,220,211 | +$29,068,777 | $1.78 | 48 |
| 2024 Q4 | 14,964,504 | $47,212,864 | +$5,023,549 | $3.16 | 51 |
| 2024 Q3 | 11,974,976 | $24,667,146 | +$1,827,419 | $2.06 | 51 |
| 2024 Q2 | 11,470,837 | $16,746,144 | -$3,322,352 | $1.46 | 63 |
| 2024 Q1 | 13,209,848 | $30,910,957 | +$1,200,705 | $2.34 | 59 |
| 2023 Q4 | 12,774,914 | $25,805,815 | -$10,140,228 | $2.02 | 62 |
| 2023 Q3 | 14,216,215 | $68,812,109 | +$1,540,803 | $4.84 | 69 |
| 2023 Q2 | 13,790,216 | $94,355,740 | -$714,623 | $6.84 | 65 |
| 2023 Q1 | 13,831,279 | $100,129,503 | -$16,765,639 | $7.24 | 68 |
| 2022 Q4 | 15,301,334 | $192,201,785 | +$3,741,246 | $12.83 | 73 |
| 2022 Q3 | 14,991,886 | $211,814,933 | +$32,802,356 | $14.13 | 65 |
| 2022 Q2 | 12,823,915 | $158,008,315 | +$4,841,924 | $12.32 | 65 |
| 2022 Q1 | 12,574,186 | $213,400,829 | -$7,136,755 | $16.97 | 51 |
| 2021 Q4 | 12,184,052 | $294,238,682 | +$23,944,526 | $24.15 | 44 |
| 2021 Q3 | 11,096,563 | $324,110,000 | +$324,110,000 | $29.37 | 30 |